Transplantation in Hematology and Oncology II by W.E. BerdelTransplantation in Hematology and Oncology II by W.E. Berdel

Transplantation in Hematology and Oncology II

EditorW.E. Berdel, H. Jürgens, Thomas Büchner

Paperback | October 28, 2012

Pricing and Purchase Info

$294.04 online 
$310.95 list price save 5%
Earn 1470 plum® points

In stock online

Ships free on orders over $25

Not available in stores


Transferring hematopoietic stem cells and immune cells has continued to be a promising therapeutic alternative and a fascinating area of cell biology as well as a field of persistent procedural problems. This explains why substantial parts of basic research on cell growth and differentiation, immune tolerance and antitumor effects, gene transfer, minimal residual disease and supportive care have settled around clinical transplantation in hematology and oncology. This second volume updates the current role of allogeneic and autologous transplantation in leukemias, lymphomas and solid cancers, including controversial strategies and novel experimental approaches. Outstanding representatives of leading groups guarantee first-hand information and indicate how we can work and cooperate more effectively to the benefit of our patients.
Title:Transplantation in Hematology and Oncology IIFormat:PaperbackDimensions:323 pages, 9.25 × 6.1 × 0 inPublished:October 28, 2012Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642626602

ISBN - 13:9783642626609

Look for similar items by category:


Table of Contents

From the contents: Cellular Therapy: Targets and Effectors. Adoptive immunotherapy in chimeras.- New Conditioning Strategies in Allogeneic Stem Cell Transplantation. Intensification of the conditioning regimen for patients with high-risk AML and MDS.- Stem Cell Mobilisation, Processing and Characteristics. A "single"-delayed application of G-CSF after autologous peripheral blood stem cell transplantation.- Cord Blood Transplantation. Lymphocyte subset reconstitution after cord blood transplantation.- Mismatched Donor Transplantation. Bone marrow transplantation from mismatched unrelated donors.- Clinical Transplantation - Hematologic Malignancies. Autografting and allografting for chronic lymphocytic leukemia.- Clinical Transplantation - Solid Tumors. Autologous transplantation in breast cancer in Europe.- Anti-angiogenesis. Angiogenesis inhibitor TNP-470 during bone marrow transplant and in minimal residual disease.- Challenges in the Treatment of Fungal Infections.